Brokerages Set Lakeland Industries, Inc. (NASDAQ:LAKE) Target Price at $15.20

Lakeland Industries, Inc. (NASDAQ:LAKE) has been given an average recommendation of “Hold” by the five analysts that are presently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating on the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $16.00.

Several brokerages have recently weighed in on LAKE. Maxim Group set a $16.00 target price on Lakeland Industries in a research note on Monday, April 20th. DA Davidson upped their target price on Lakeland Industries from $14.00 to $18.00 and gave the stock a “buy” rating in a research note on Thursday. Lake Street Capital reduced their target price on Lakeland Industries from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Friday, April 17th. Wall Street Zen raised Lakeland Industries from a “sell” rating to a “hold” rating in a research note on Sunday. Finally, Weiss Ratings downgraded Lakeland Industries from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. Private Capital Management LLC raised its stake in shares of Lakeland Industries by 2.8% during the 4th quarter. Private Capital Management LLC now owns 1,202,433 shares of the medical instruments supplier’s stock worth $10,630,000 after buying an additional 32,945 shares during the period. Royce & Associates LP increased its position in shares of Lakeland Industries by 10.0% during the third quarter. Royce & Associates LP now owns 1,178,670 shares of the medical instruments supplier’s stock worth $17,444,000 after purchasing an additional 107,100 shares in the last quarter. Pacific Ridge Capital Partners LLC increased its position in shares of Lakeland Industries by 62.3% during the fourth quarter. Pacific Ridge Capital Partners LLC now owns 772,015 shares of the medical instruments supplier’s stock worth $6,825,000 after purchasing an additional 296,222 shares in the last quarter. Vanguard Group Inc. increased its position in shares of Lakeland Industries by 2.3% during the third quarter. Vanguard Group Inc. now owns 486,524 shares of the medical instruments supplier’s stock worth $7,201,000 after purchasing an additional 10,764 shares in the last quarter. Finally, Geode Capital Management LLC increased its position in shares of Lakeland Industries by 115.9% during the second quarter. Geode Capital Management LLC now owns 217,786 shares of the medical instruments supplier’s stock worth $2,964,000 after purchasing an additional 116,901 shares in the last quarter. 71.69% of the stock is owned by institutional investors and hedge funds.

Lakeland Industries Stock Performance

Shares of NASDAQ:LAKE opened at $10.98 on Wednesday. The company has a current ratio of 3.09, a quick ratio of 1.34 and a debt-to-equity ratio of 0.20. The company has a market capitalization of $108.37 million, a PE ratio of -5.15 and a beta of 1.45. The business has a 50 day moving average of $10.05 and a two-hundred day moving average of $9.80. Lakeland Industries has a 12-month low of $7.15 and a 12-month high of $18.00.

Lakeland Industries (NASDAQ:LAKE) last announced its earnings results on Tuesday, June 9th. The medical instruments supplier reported $0.04 earnings per share for the quarter, topping the consensus estimate of ($0.14) by $0.18. The business had revenue of $47.42 million during the quarter, compared to the consensus estimate of $47.36 million. Lakeland Industries had a negative return on equity of 6.64% and a negative net margin of 10.87%. As a group, analysts forecast that Lakeland Industries will post 0.22 EPS for the current year.

Lakeland Industries Company Profile

Lakeland Industries, Inc (NASDAQ:LAKE) is a global provider of high-performance protective apparel and accessories designed to safeguard workers in industrial, healthcare, laboratory, and emergency response environments. The company’s expertise lies in producing garments that shield against chemical, biological, radiological, and thermal risks, supporting safety protocols in sectors such as oil and gas, petrochemicals, pharmaceuticals, and first responders.

The product portfolio encompasses both single-use and reusable solutions, including chemical protective coveralls, flame-resistant garments, arc flash clothing, medical isolation gowns, and cleanroom suits.